The Latest Cardiac and Vascular News
Grant Will Support Continued Development of CoreMap’s Technology to Enable Curative, Patient-Specific Treatment of Atrial Fibrillation BURLINGTON, Vt., Sept. 08, 2020 (GLOBE NEWSWIRE) — CoreMap, Inc. announced today that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Science Foundation (NSF) to support development of […]
Ramesh Jain – Father of Multimedia Computing Appointed as Chief Technical Advisor of Huami AI Research Institute, Announced on Huami’s 1st Innovation Conference “AI to Decode Future” SHENZHEN, China, June 17, 2020 /PRNewswire/ — The Global Top 5 wearable brand[1], Amazfit’s mother company, Huami (NYSE: HMI) , made its second wearable AI chip […]
MARLBOROUGH, Mass., June 16, 2020 /PRNewswire/ — CardioFocus, Inc. today announced that the first U.S. patients have been treated commercially with the recently-approved HeartLight® X3 Endoscopic Ablation System. The revolutionary cardiac ablation technology is designed to treat drug refractory, symptomatic paroxysmal atrial fibrillation (AFib), the most common heart rhythm disorder. Henry D. Huang, M.D., FACC, […]
Sub-Analysis Of Large Multi-Center Study Shows DX Technology Provides Similar CRT Responses To Conventional Three-Lead System With Reduced Risk LAKE OSWEGO, Ore., May 27, 2020 /PRNewswire/ — Results recently published in the Journal of Cardiovascular Electrophysiology confirm that BIOTRONIK’s unique two-lead CRT-DX system provides equivalent therapy to more conventional three-lead systems. CRT-DX systems consist of […]
New data provide additional evidence of efficacy for Gencaro compared to active control in a pharmacogenetically-defined HF population at risk for AF recurrence ° 26% reduction in total time spent in AF (p < 0.001) ° 30% decrease in AF interventions and cardiovascular adverse events (p = 0.008) ° 55% lower incidence […]
Study part of broader Company efforts to make health tools more accessible and reduce the risk of life-threatening events like stroke SAN FRANCISCO–(BUSINESS WIRE)–Fitbit (NYSE: FIT) today launched the Fitbit Heart Study, its first large-scale, virtual study to validate the use of its wearable technology to identify episodes of irregular heart rhythm […]
– Sotalol IV is now approved for 1-day hospital outpatient initiation of AFib therapy and faster dose escalations for existing patients – New FDA-approved dosing, monitoring and evaluation shortens the hospital stay from 3 days to 1 day – The new initiation provides physicians with a faster and safe way […]
S4 Medical oversubscribes round in preparation for clinical studies COLUMBUS, Ohio, Feb. 13, 2020 /PRNewswire/ — S4 Medical, an innovative medical device company focused on protecting the esophagus from thermal damage during catheter ablation procedures, announced an oversubscribed round of funding following its successful human study. While catheter ablation is an effective […]
MARLBOROUGH, Mass., Feb. 4, 2020 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced that the company has submitted a pre-market approval (PMA) supplement to the U.S. Food and Drug Administration (FDA) for the HeartLight X3 Endoscopic Ablation System for the treatment of AFib. This […]
CHICAGO–(BUSINESS WIRE)–Chicago-based medical device firm Attune Medical announced the presentation of clinical results from the largest device study to date designed to evaluate the performance of its ensoETM patient temperature management device as an aid in the reduction of esophageal injury during cardiac ablation, a common treatment for atrial fibrillation. […]
